Growth Metrics

Innoviva (INVA) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for Innoviva (INVA) over the last 13 years, with Q3 2025 value amounting to $13.6 million.

  • Innoviva's Current Deferred Revenue rose 179274.76% to $13.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.6 million, marking a year-over-year increase of 179274.76%. This contributed to the annual value of $1.1 million for FY2024, which is 1182.46% down from last year.
  • As of Q3 2025, Innoviva's Current Deferred Revenue stood at $13.6 million, which was up 179274.76% from $3.1 million recorded in Q2 2025.
  • Innoviva's 5-year Current Deferred Revenue high stood at $13.6 million for Q3 2025, and its period low was $717000.0 during Q3 2024.
  • Its 4-year average for Current Deferred Revenue is $2.7 million, with a median of $1.5 million in 2023.
  • Per our database at Business Quant, Innoviva's Current Deferred Revenue crashed by 7372.46% in 2024 and then skyrocketed by 179274.76% in 2025.
  • Innoviva's Current Deferred Revenue (Quarter) stood at $2.1 million in 2022, then crashed by 39.02% to $1.3 million in 2023, then dropped by 11.82% to $1.1 million in 2024, then skyrocketed by 1105.24% to $13.6 million in 2025.
  • Its last three reported values are $13.6 million in Q3 2025, $3.1 million for Q2 2025, and $1.0 million during Q1 2025.